Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oc-10x (2 trials)
Diabetic Retinopathy (Phase 2)
Retinal Diseases (Phase 2)
Trials (2 total)
Trial APIs (1 total)